Education
About Us
Working with TipRanks
Follow Us
Intervacc AB (SE:IVACC)
:IVACC
IVACC Stock Chart & Stats
Day’s Range― - ―
52-Week Rangekr0.73 - kr3.81
Previous CloseN/A
Volume791.15K
Average Volume (3M)916.03K
Market Cap
€402.84M
Enterprise ValueN/A
Total Cash (Recent Filing)€34.40M
Total Debt (Recent Filing)kr0.00
Price to Earnings (P/E)―
Beta0.86
Next Earnings
Aug 29, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.08
Shares Outstanding340,813,200
10 Day Avg. Volume1,402,458
30 Day Avg. Volume916,029
Financial Highlights & Ratios
PEG Ratio-0.20
Price to Book (P/B)0.57
Price to Sales (P/S)0.00
P/FCF Ratio-6.64
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
IVACC FAQ
What was Intervacc AB’s price range in the past 12 months?
Intervacc AB lowest stock price was kr0.73 and its highest was kr3.81 in the past 12 months.
What is Intervacc AB’s market cap?
Intervacc AB’s market cap is €402.84M.
When is Intervacc AB’s upcoming earnings report date?
Intervacc AB’s upcoming earnings report date is Aug 29, 2025 which is in 101 days.
How were Intervacc AB’s earnings last quarter?
Intervacc AB released its earnings results on May 14, 2025. The company reported -kr0.079 earnings per share for the quarter, beating the consensus estimate of -kr0.189 by kr0.11.
Is Intervacc AB overvalued?
According to Wall Street analysts Intervacc AB’s price is currently Overvalued.
Does Intervacc AB pay dividends?
Intervacc AB does not currently pay dividends.
What is Intervacc AB’s EPS estimate?
Intervacc AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Intervacc AB have?
Intervacc AB has 340,813,200 shares outstanding.
What happened to Intervacc AB’s price movement after its last earnings report?
Intervacc AB reported an EPS of -kr0.079 in its last earnings report, beating expectations of -kr0.189. Following the earnings report the stock price went up 3.361%.
Which hedge fund is a major shareholder of Intervacc AB?
Currently, no hedge funds are holding shares in SE:IVACC
---
Company Description
Intervacc AB
Intervacc AB (publ), a biotechnology company, engages in the research and development of vaccines for bacterial infections in animal health care. The company devlops vaccines for horses, piglets, and dairy cows. It offers Strangvac, a vaccine for equine strangles. The company also markets and sells veterinary medicines; and provides diagnostic services in veterinary bacteriology for veterinary clinics and stud farms. In addition, it is developing vaccines against streptococcus suis and staphylococcus aureus-infections. It serves customers in Nordic countries and the Baltic states. The company is based in Hägersten, Sweden.
---
Technical Analysis
Oncopeptides AB
―
Xbrane Biopharma AB
―
Guard Therapeutics International AB
―
Immunicum AB
―
Cantargia AB
―
---